Emopamil

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M514041RF7. European Medicines Agency schedules Emopamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06510MIG. Emopamil generally arises in the molecular formula C23H30N2. The term EMOPAMIL is an International Non-Proprietary Name or INN. EMOPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule emopamil under HS 29269095 and SITC 51484. As of Q4 2014, EMOPAMIL remains the US FDA Preferred Term for this commodity. Emopamil bears US NLM identifiers UMLS ID C0059080 and NCI Concept Code C74417. SMILES: N(CCCC(C(C)C)(c1ccccc1)C#N)(CCc1ccccc1)C.